S&P 500   3,379.88 (+1.39%)
DOW   27,921.35 (+0.85%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
S&P 500   3,379.88 (+1.39%)
DOW   27,921.35 (+0.85%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
S&P 500   3,379.88 (+1.39%)
DOW   27,921.35 (+0.85%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
S&P 500   3,379.88 (+1.39%)
DOW   27,921.35 (+0.85%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
Log in

NASDAQ:ACORAcorda Therapeutics SEC Filings & 10K Form

$0.68
-0.03 (-3.58 %)
(As of 08/12/2020 01:47 PM ET)
Add
Compare
Today's Range
$0.68
Now: $0.68
$0.72
50-Day Range
$0.63
MA: $0.73
$0.84
52-Week Range
$0.60
Now: $0.68
$4.46
Volume17,187 shs
Average Volume3.52 million shs
Market Capitalization$32.86 million
P/E RatioN/A
Dividend YieldN/A
Beta1.5

SEC Filings

Acorda Therapeutics (NASDAQ:ACOR) SEC Filings

DateFilerForm TypeView
08/10/2020
3:04 PM
Acorda Therapeutics (Filer)
Form DEFA14A
07/31/2020
11:58 AM
Acorda Therapeutics (Filer)
Form DEFA14A
07/31/2020
11:47 AM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/27/2020
4:15 PM
Acorda Therapeutics (Filer)
Form DEFA14A
07/27/2020
4:07 PM
Acorda Therapeutics (Filer)
Form DEFA14A
07/24/2020
3:45 PM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2020
3:04 PM
Acorda Therapeutics (Filer)
Form DEFA14A
07/14/2020
3:05 PM
Acorda Therapeutics (Filer)
Form DEFA14A
07/10/2020
9:39 AM
Acorda Therapeutics (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
07/06/2020
11:15 PM
Acorda Therapeutics (Filer)
Form EFFECT
07/06/2020
8:26 AM
Acorda Therapeutics (Filer)
Form DEF 14A
06/29/2020
8:01 AM
Acorda Therapeutics (Filer)
Form PRE 14A
06/29/2020
7:40 AM
Acorda Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/17/2020
7:45 PM
Acorda Therapeutics (Issuer)
RAUSCHER STEVEN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:03 PM
Acorda Therapeutics (Issuer)
STRADER CATHERINE D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:02 PM
Acorda Therapeutics (Issuer)
Randall Lorin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:00 PM
Acorda Therapeutics (Issuer)
PANEM SANDRA PHD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
3:55 PM
Acorda Therapeutics (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
5:35 AM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2020
9:13 AM
Acorda Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
05/11/2020
2:41 PM
Acorda Therapeutics (Filer)
Form CT ORDER
05/11/2020
2:00 PM
Acorda Therapeutics (Filer)
Form CT ORDER
04/28/2020
4:15 PM
Acorda Therapeutics (Filer)
Form DEF 14A
02/13/2020
6:13 AM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2020
11:16 PM
Acorda Therapeutics (Filer)
Form EFFECT
01/15/2020
3:13 PM
Acorda Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/15/2020
11:15 AM
Acorda Therapeutics (Subject)
SYMPHONY ASSET MANAGEMENT LLC (Filed by)
Form SC 13G
01/15/2020
6:08 AM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
8:08 AM
Acorda Therapeutics (Subject)
CANYON CAPITAL ADVISORS LLC (Filed by)
Form SC 13G
01/02/2020
4:10 PM
Acorda Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
12/26/2019
7:21 AM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2019
6:53 AM
Acorda Therapeutics (Issuer)
Wasman Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
6:51 AM
Acorda Therapeutics (Issuer)
Sabella Lauren M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
6:49 AM
Acorda Therapeutics (Issuer)
LAWRENCE DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
6:47 AM
Acorda Therapeutics (Issuer)
COHEN RON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
6:06 AM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
7:17 AM
Acorda Therapeutics (Issuer)
Wasman Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
7:15 AM
Acorda Therapeutics (Issuer)
Sabella Lauren M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
7:06 AM
Acorda Therapeutics (Issuer)
LAWRENCE DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
7:02 AM
Acorda Therapeutics (Issuer)
COHEN RON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
6:58 AM
Acorda Therapeutics (Issuer)
BLANK BURKHARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
6:26 AM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2019
4:11 PM
Acorda Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2019
3:01 PM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2019
3:18 PM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2019
3:04 PM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2019
7:00 AM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2019
8:51 AM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2019
12:28 PM
Acorda Therapeutics (Filer)
Form CT ORDER
08/13/2019
12:16 PM
Acorda Therapeutics (Filer)
Form CT ORDER
08/13/2019
11:49 AM
Acorda Therapeutics (Filer)
Form CT ORDER
08/13/2019
11:47 AM
Acorda Therapeutics (Filer)
Form CT ORDER
08/09/2019
3:02 PM
Acorda Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2019
6:27 AM
Acorda Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
3:01 PM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2019
8:15 AM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2019
7:03 AM
Acorda Therapeutics (Issuer)
STRADER CATHERINE D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
7:01 AM
Acorda Therapeutics (Issuer)
RAUSCHER STEVEN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
7:00 AM
Acorda Therapeutics (Issuer)
Randall Lorin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
6:57 AM
Acorda Therapeutics (Issuer)
PANEM SANDRA PHD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
6:55 AM
Acorda Therapeutics (Issuer)
Kelley John P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
6:54 AM
Acorda Therapeutics (Issuer)
Jensen Peder (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
6:52 AM
Acorda Therapeutics (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2019
5:58 AM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
3:11 PM
Acorda Therapeutics (Filer)
Form 8-K/A
05/07/2019
4:09 PM
Acorda Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2019
5:17 AM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
4:01 PM
Acorda Therapeutics (Filer)
Form DEF 14A
03/12/2019
3:25 PM
Acorda Therapeutics (Issuer)
Wasman Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2019
3:20 PM
Acorda Therapeutics (Issuer)
Jensen Peder (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2019
3:15 PM
Acorda Therapeutics (Issuer)
Hindman Andrew A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2019
3:13 PM
Acorda Therapeutics (Issuer)
COHEN RON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2019
3:11 PM
Acorda Therapeutics (Issuer)
BLANK BURKHARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2019
6:11 AM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2019
4:08 PM
Acorda Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2019
3:21 PM
Acorda Therapeutics (Issuer)
Wasman Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2019
3:15 PM
Acorda Therapeutics (Issuer)
Hindman Andrew A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2019
3:11 PM
Acorda Therapeutics (Issuer)
COHEN RON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
4:22 PM
Acorda Therapeutics (Subject)
Partner Fund Management, L.P. (Filed by)
Form SC 13G/A
02/14/2019
7:35 AM
Acorda Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/11/2019
10:14 AM
Acorda Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/08/2019
6:10 AM
Acorda Therapeutics (Subject)
DIMENSIONAL FUND ADVISORS LP (Filed by)
Form SC 13G/A
02/04/2019
6:11 AM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2019
3:28 PM
Acorda Therapeutics (Issuer)
MINDICH JEREMY (Reporting)
SCOPIA CAPITAL MANAGEMENT LP (Reporting)
Scopia Management, Inc. (Reporting)
SIROVICH MATTHEW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2019
3:09 PM
Acorda Therapeutics (Issuer)
MINDICH JEREMY (Reporting)
SCOPIA CAPITAL MANAGEMENT LP (Reporting)
Scopia Management, Inc. (Reporting)
SIROVICH MATTHEW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
3:06 PM
Acorda Therapeutics (Issuer)
MINDICH JEREMY (Reporting)
SCOPIA CAPITAL MANAGEMENT LP (Reporting)
Scopia Management, Inc. (Reporting)
SIROVICH MATTHEW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:51 PM
Acorda Therapeutics (Subject)
SCOPIA CAPITAL MANAGEMENT LP (Filed by)
Form SC 13D/A
01/22/2019
3:18 PM
Acorda Therapeutics (Issuer)
MINDICH JEREMY (Reporting)
SCOPIA CAPITAL MANAGEMENT LP (Reporting)
Scopia Management, Inc. (Reporting)
SIROVICH MATTHEW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
5:58 AM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2019
3:06 PM
Acorda Therapeutics (Issuer)
MINDICH JEREMY (Reporting)
SCOPIA CAPITAL MANAGEMENT LP (Reporting)
Scopia Management, Inc. (Reporting)
SIROVICH MATTHEW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2019
3:32 PM
Acorda Therapeutics (Issuer)
MINDICH JEREMY (Reporting)
SCOPIA CAPITAL MANAGEMENT LP (Reporting)
Scopia Management, Inc. (Reporting)
SIROVICH MATTHEW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2019
3:18 PM
Acorda Therapeutics (Issuer)
MINDICH JEREMY (Reporting)
SCOPIA CAPITAL MANAGEMENT LP (Reporting)
Scopia Management, Inc. (Reporting)
SIROVICH MATTHEW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2019
3:22 PM
Acorda Therapeutics (Issuer)
MINDICH JEREMY (Reporting)
SCOPIA CAPITAL MANAGEMENT LP (Reporting)
Scopia Management, Inc. (Reporting)
SIROVICH MATTHEW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
3:05 PM
Acorda Therapeutics (Subject)
SCOPIA CAPITAL MANAGEMENT LP (Filed by)
Form SC 13D/A
01/07/2019
3:08 PM
Acorda Therapeutics (Issuer)
MINDICH JEREMY (Reporting)
SCOPIA CAPITAL MANAGEMENT LP (Reporting)
Scopia Management, Inc. (Reporting)
SIROVICH MATTHEW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
7:09 AM
Acorda Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2018
3:11 PM
Acorda Therapeutics (Issuer)
MINDICH JEREMY (Reporting)
SCOPIA CAPITAL MANAGEMENT LP (Reporting)
Scopia Management, Inc. (Reporting)
SIROVICH MATTHEW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2018
7:16 AM
Acorda Therapeutics (Issuer)
Wasman Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2018
7:14 AM
Acorda Therapeutics (Issuer)
Sabella Lauren M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2018
7:13 AM
Acorda Therapeutics (Issuer)
LAWRENCE DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.